$294 Million is the total value of Affinity Asset Advisors, LLC's 72 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XLRN | ACCELERON PHARMA INC | $6,102,000 | +6.0% | 45,000 | 0.0% | 2.07% | -32.1% | |
| RETROPHIN INCnote 2.500% 9/1 | $4,069,000 | +0.8% | 4,000,000 | 0.0% | 1.38% | -35.4% | ||
| CERE | CEREVEL THERAPEUTICS HLDNG I | $3,707,000 | -17.2% | 270,000 | 0.0% | 1.26% | -46.9% | |
| BCTG | BCTG ACQUISITION CORP | $1,112,000 | -2.8% | 100,000 | 0.0% | 0.38% | -37.6% | |
| CCCC | C4 THERAPEUTICS INC | $740,000 | +11.6% | 20,000 | 0.0% | 0.25% | -28.5% | |
| PCVX | VAXCYTE INC | $593,000 | -25.6% | 30,000 | 0.0% | 0.20% | -52.4% | |
| AXSM | AXSOME THERAPEUTICS INC | $566,000 | -30.6% | 10,000 | 0.0% | 0.19% | -55.6% | |
| CEREW | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/2020 | $312,000 | -23.7% | 72,466 | 0.0% | 0.11% | -51.2% | |
| ZYNE | ZYNERBA PHARMACEUTICALS INC | $62,000 | +40.9% | 13,285 | 0.0% | 0.02% | -8.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MORPHIC HOLDING INC | 12 | Q3 2023 | 6.9% |
| KURA ONCOLOGY INC | 12 | Q3 2023 | 7.2% |
| CELLDEX THERAPEUTICS INC NEW | 12 | Q3 2023 | 1.9% |
| IMMATICS N.V | 12 | Q3 2023 | 0.4% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.4% |
| ESTABLISHMENT LABS HLDGS INC | 11 | Q3 2023 | 8.3% |
| VINCERX PHARMA INC | 11 | Q2 2023 | 4.5% |
| ASCENDIS PHARMA A/S | 11 | Q3 2023 | 4.9% |
| CYTOKINETICS INC | 11 | Q3 2023 | 2.6% |
| INARI MED INC | 10 | Q1 2023 | 6.4% |
View Affinity Asset Advisors, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 03, 2023 | 7,477,000 | 9.2% |
View Affinity Asset Advisors, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-05-07 |
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-21 |
| 13F-HR | 2023-08-14 |
| SC 13G | 2023-07-03 |
| 13F-HR | 2023-05-15 |
View Affinity Asset Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.